Browse the Full Event Guide to Discover:

24+

Expert Speakers from across R&D, preclinical and clinical development

4

Interactive workshops on crucial topics spanning delivery, animal models, endpoint selection and regulatory challenges

3

Days of cutting edge content from AAVs and innovating vectors to confirming suitable clinical endpoints

GTxO Brochure

Having trouble downloading the brochure? Let us know and we’ll email it to you instead

Peter Francis

“I'm delighted to speak at this conference to provide insights into the exciting and fast progressing field of visual optogenetics and how Ray Therapeutics is pioneering the development and validation of clinical endpoints.”

Peter Francis, Chief Scientific Officer & Chief Medical Officer Ray Therapeutics, Inc.

Companies on the Agenda Include:

Nanoscope Therapeutics Logo
logo-2x
logo-iveric
0_gh93YzXOmfNh2dFC
8iGViy2y_400x400
images
clearside-logo-2024
f6fb4bba7c938193c37684f8d7e86955
Dyno Therapeutics, Inc. logo
background remover
images (1)
csm_sparingvision_b63cf07344_1a8430b97d
Ray_therapeutics_final_logo-01
1630554211394
everads-logo
Spotlight_Logo_New_transparent
Avista_Logo_Full_Color_RGB
images (2)
images (3)
splicebio-1
blue_gen_therapeutics_foundation_logo